RAYMOND JAMES & ASSOCIATES - VIRIOS THERAPEUTICS INC ownership

VIRIOS THERAPEUTICS INC's ticker is VIRI and the CUSIP is 92829J104. A total of 24 filers reported holding VIRIOS THERAPEUTICS INC in Q3 2023. The put-call ratio across all filers is - and the average weighting 0.0%.

Quarter-by-quarter ownership
RAYMOND JAMES & ASSOCIATES ownership history of VIRIOS THERAPEUTICS INC
ValueSharesWeighting
Q3 2023$27,744
-33.0%
30,0000.0%0.00%
Q2 2023$41,400
+275.5%
30,0000.0%0.00%
Q1 2023$11,025
+55.7%
30,0000.0%0.00%
Q4 2022$7,080
-45.5%
30,000
-14.3%
0.00%
Q3 2022$13,00035,0000.00%
Other shareholders
VIRIOS THERAPEUTICS INC shareholders Q3 2023
NameSharesValueWeighting ↓
MASTERS CAPITAL MANAGEMENT LLC 650,000$3,439,0000.14%
Cetera Advisors LLC 48,432$256,0000.01%
CAPTRUST FINANCIAL ADVISORS 40,145$212,0000.00%
TWO SIGMA INVESTMENTS, LP 17,776$94,0000.00%
OSAIC HOLDINGS, INC. 1,808$10,0000.00%
WELLS FARGO & COMPANY/MN 45$00.00%
CONCOURSE FINANCIAL GROUP SECURITIES, INC. 0$00.00%
GEODE CAPITAL MANAGEMENT, LLC 20,429$108,0000.00%
MILLENNIUM MANAGEMENT LLC 28,781$152,0000.00%
BlackRock Inc. 15,856$84,0000.00%
View complete list of VIRIOS THERAPEUTICS INC shareholders